Welcome

The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.

Centers

CO-ADD (Community for Open Antimicrobial Drug Discovery)

CO-ADD is a not-for-profit initiative led by academics.

Our goal is to screen compounds for antimicrobial activity for academic research groups from anywhere in the world for free. We make no claim to IP or results.

We aim to help resea...

View all

Partnerships

Novo Nordisk and Oxford to Develop Drugs to Treat Rheumatoid Arthritis and Other Inflammatory Diseases

Novo Nordisk and Kennedy Institute of Rheumatology at Oxford University have entered into partnership to develop new drugs to treat Rheumatoid Arthritis and other inflammatory disorders. Novo Nordisk will provide research funding support to ten Ox...

View all

Jobs

  • POSTDOCTORAL POSITIONS IN DRUG DISCOVERY